Liver function and prognosis, and influence of sacubitril/valsartan in patients with heart failure with reduced ejection fraction-Reference-Cited by-同舟云学术

Liver function and prognosis, and influence of sacubitril/valsartan in patients with heart failure with reduced ejection fraction

Published:2020-05-14 Issue:9 Volume:22 Page:1662-1671
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Suzuki Kota¹,Claggett Brian¹,Minamisawa Masatoshi¹,Packer Milton²,Zile Michael R.³,Rouleau Jean⁴,Swedberg Karl⁵,Lefkowitz Martin⁶,Shi Victor⁶,McMurray John J.V.⁷,Zucker Stephen D.⁸,Solomon Scott D.¹

Affiliation:

1. Division of Cardiovascular Medicine Brigham and Women's Hospital Boston MA USA

2. Baylor Heart and Vascular Institute, Baylor University Medical Center Dallas TX USA

3. Medical University of South Carolina and Ralph H. Johnson Department of Veterans Affairs Medical Center Charleston SC USA

4. University of Montreal Montreal Quebec Canada

5. University of Gothenburg Gothenburg Sweden

6. Novartis East Hanover NJ USA

7. University of Glasgow Glasgow UK

8. Division of Gastroenterology, Hepatology, and Endoscopy Brigham and Women's Hospital Boston MA USA

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.1853

Reference30 articles.

1. Interaction between gut microbiome and cardiovascular disease

2. Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association

3. Left ventricular heart failure and pulmonary hypertension

4. The Brain–Heart Connection

5. Cardiohepatic Interactions in Heart Failure

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Direct Bilirubin, but not Indirect Bilirubin, is Associated with Short-term Adverse Events in HFpEF;Current Gene Therapy;2024-08

2. Molecular Mechanisms of the Failing Heart: A Fatal Regression?;Journal of Asian Pacific Society of Cardiology;2024-06-13

3. Angiotensin receptor blocker-neprilysin inhibitor for heart failure with reduced ejection fraction;Pharmacological Research;2024-06

4. The Barcelona Bio-Heart Failure Risk Calculator may predict one-year mortality in patients with advanced heart failure;Polish Archives of Internal Medicine;2024-04-24

5. A follow-up program in patients after hospitalization for heart failure: long-term health related quality of life and associated factors;Frontiers in Cardiovascular Medicine;2024-04-05